Medicaid Prescription Drug Spending and Use
This issue paper provides the latest data and trend analysis on Medicaid prescription drug spending and utilization. In 2002, Medicaid programs spent $30 billion for prescribed drugs. Issue Paper (.
View the Latest: Prescription Drugs
Filter
-
-
Issues Surrounding the “Clawback” or State Contributions Towards Medicare Drug Coverage: A Conference Call Discussion
Other PostIssues Surrounding the “Clawback” or State Contributions Towards Medicare Drug Coverage: A Conference Call Discussion As part of the Medicare Prescription Drug, Improvement, and Modernization Act (MMA) of 2003 signed into law last year, Congress included a financing provision that requires a monthly payment from each state to the Medicare program beginning in January 2006.
-
Additional Help with Rx Drug Costs For Low-Income People on Medicare
Other PostAdditional Help with Prescription Drug Costs For Low-Income People on Medicare (For 2007 Benefits and Cost-Sharing) As of 2007, Medicare helps pay for outpatient prescription drugs. Medicare provides additional help with drug costs to beneficiaries who qualify based on low incomes and limited resources.
-
Trends in Medicare Supplemental Insurance and Prescription Drug Benefits, 1996-2001Data Update
ReportTrends in Medicare Supplemental Insurance and Prescription Drug Benefits, 1996-2001 Data Update This data update provides estimates of supplemental insurance and prescription drug coverage rates and trends between 1996 and 2001, which will help to provide important context for assessing future changes in supplemental insurance and drug coverage rates after provisions of the Medicare drug…
-
Political History of Medicare and Prescription Drug Coverage
Other PostA Political History of Medicare and Prescription Drug Coverage Thomas R. Oliver, Philip R. Lee, and Helene L. Lipton This article examines the history of efforts to add prescription drug coverage to the Medicare program. It identifies several important patterns in policymaking over four decades.
-
Reactions to the New Medicare Law, Findings Based on Focus Groups with People on Medicare
ReportThis report, Reactions to the New Medicare Drug Law, produced jointly by a bipartisan team of pollsters from Public Opinion Strategies and Peter D. Hart Research Associates, presents key findings from ten focus groups of people on Medicare in three cities: Pittsburgh, PA; Kansas City, KS, and Washington, DC.
-
The Medicare Prescription Drug Law – What Are Seniors Saying?
Other PostAs the first phase of the new Medicare prescription drug law takes effect, the Kaiser Family Foundation commissioned focus groups conducted by Bill McInturff of Public Opinion Strategies and Geoff Garin of Peter D. Hart Research Associates in consultation with Foundation staff.
-
Selected Findings on the New Medicare Prescription Drug Law
ReportThis chartpack includes recent survey results on the Medicare prescription drug law and seniors' use of the Internet. Chartpack (.
-
The State of Retiree Health Benefits: Historical Trends and Future Uncertainties
EventTricia Neuman, Vice President and Director of the Medicare Policy Project for the Kaiser Family Foundation, testified on Monday, May 17, at a
-
The Medicare Prescription Drug Discount Card Program: Implications for Low-income Medicare Beneficiaries
Issue Brief- Issue Paper This Issue Paper describes the discount card and low-income assistance programs and discusses their implications for low-income Medicare beneficiaries and state Medicaid programs. Issue Paper (.